An open-label, drug-drug interaction study designed to evaluate the potential effect of miricorilant on cytochrome P450 2C8, 2C9, 3A4, uridine-diphospho-glucuronosyltransferase 1A1 enzyme activity, and breast cancer resistance protein activity using probe substrates in healthy male and female subjects
An open label, single-dose, single-period study designed to assess the mass balance recovery, metabolite profile and metabolite identification of [14C]-CORT125329 in healthy male subjects
100 Clinical Results associated with Corcept Therapeutics (United States)
0 Patents (Medical) associated with Corcept Therapeutics (United States)
100 Deals associated with Corcept Therapeutics (United States)
100 Translational Medicine associated with Corcept Therapeutics (United States)